Palomer Tarridas, Francesc XavierBarroso Fernández, EmmaPizarro Delgado, JavierPeña, LucíaBotteri, GaiaZarei, MohammadAguilar, DavidMontori Grau, MartaVázquez Carrera, Manuel2020-04-272020-04-272018-03-201661-6596https://hdl.handle.net/2445/157699Research in recent years on peroxisome proliferator-activated receptor (PPAR)β/δ indicates that it plays a key role in the maintenance of energy homeostasis, both at the cellular level and within the organism as a whole. PPARβ/δ activation might help prevent the development of metabolic disorders, including obesity, dyslipidaemia, type 2 diabetes mellitus and non-alcoholic fatty liver disease. This review highlights research findings on the PPARβ/δ regulation of energy metabolism and the development of diseases related to altered cellular and body metabolism. It also describes the potential of the pharmacological activation of PPARβ/δ as a treatment for human metabolic disorders14 p.application/pdfengcc-by (c) Palomer Tarridas, Francesc Xavier et al., 2018http://creativecommons.org/licenses/by/3.0/esHomeòstasiObesitatDiabetisMetabolisme cel·lularFarmacologiaHomeostasisObesityDiabetesCell metabolismPharmacologyPPARβ/δ: A Key Therapeutic Target in Metabolic Disordersinfo:eu-repo/semantics/article6807892020-04-27info:eu-repo/semantics/openAccess29558390